Recce Pharmaceuticals Ltd
RECEF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$13,693 | -$7,735 | -$10,200 | -$7,462 |
| Dep. & Amort. | $270 | $86 | $173 | $193 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $953 | $384 | $0 | $0 |
| Change in WC | -$182 | $0 | $0 | $0 |
| Other Non-Cash | -$866 | $341 | $3,535 | $1,138 |
| Operating Cash Flow | -$13,518 | -$6,924 | -$6,491 | -$6,517 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$8 | -$18 | -$36 | -$106 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | -$28 | -$390 | $34 | -$34 |
| Investing Cash Flow | -$36 | -$408 | -$2 | -$140 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $7,366 | -$1,480 |
| Stock Issued | $0 | $0 | -$2 | $10,585 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $22,059 | $4,860 | -$464 | $0 |
| Financing Cash Flow | $22,059 | $4,860 | $6,900 | $9,105 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$1,944 | $1,944 | $199 | $2,447 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $1,944 | $0 | $4,009 | $1,562 |
| End Cash | $0 | $1,944 | $4,207 | $4,009 |
| Free Cash Flow | -$13,527 | -$6,942 | -$6,527 | -$6,624 |